← All stories
Markets
STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

A lab that tussled with regulators over impurities found in widely used medicines has accused U.S. Pharmacopeia of making false and misleading remarks about its methods.
Covered by 1 outlet
All coverage · 1 article